文献速递胸部MR

急性COVID-19肺炎后6-24个月低场MRI监测:影响肺部磨玻璃影严重程度及演变的相关因素

Low Field MRI Surveillance 6-24 Months Post-acute COVID-19 Pneumonia: Factors Influencing Severity and Evolution of Lung Opacities.
PubMed 文献 · Acad Radiol · 2024-03-04

研究纳入104例急性COVID-19肺炎后患者共167次低场MRI检查,按四分位0-4分评分(总分0-16分,>8分中度、>12分重度),发现初始疾病严重程度与最长24个月内MRI磨玻璃影评分升高相关(p<.05),6个月后33%的检查存在中重度磨玻璃影,随机系数回归未显示总分随时间显著变化。

要点

  • 低场MRI可用于COVID-19肺炎后6-24个月肺部磨玻璃影的随访评估,总分>8分提示中重度。
  • 初始COVID-19病情严重程度与最长24个月内MRI磨玻璃影总分升高相关(p<.05)。
  • 6个月后33%的MRI检查仍可见中重度磨玻璃影,但总分随时间无显著变化。

核心结论

  • 初始COVID-19疾病严重程度与最长24个月内MRI磨玻璃影总分升高相关,6个月后低场MRI常可检出中重度磨玻璃影。

研究设计与样本

  • 研究纳入104例急性COVID-19肺炎后患者,共167次MRI检查,其中32例有多次检查、63次为连续检查。
  • 肺部表现按四分位0-4分评分,总分0分(无磨玻璃影)至16分(磨玻璃影>75%),总分>8分为中度、>12分为重度。
  • 采用Kruskal-Wallis、Mann-Whitney及Spearman秩相关评估临床与人口学因素与不同时间间隔MRI磨玻璃影严重程度的关系,并用随机系数回归评估磨玻璃影评分是否随时间变化。

关键影像表现/征象

  • 6个月后167次检查中33%存在中重度磨玻璃影(总分>8分)。
  • 6至<12个月37%(n=23/63)、12至<18个月31%(n=13/42)、18至<24个月25%(n=6/24)、>24个月50%(n=3/6)的检查存在中重度磨玻璃影。
  • 32例有连续检查的患者中,11例磨玻璃影评分从首次至末次无变化,10例下降(均值2.3,标准差1.25,范围1-4),11例升高(平均2.8,标准差1.48,范围1-7)。

诊断标准与关键数值

  • 低场MRI肺部磨玻璃影按四分位0-4分评分,总分0-16分,总分>8分定义为中度、>12分定义为重度磨玻璃影。

临床应用与阅片要点

  • 对COVID-19肺炎后6-24个月随访患者,可采用低场MRI四分位0-4分评分系统评估磨玻璃影严重程度,总分>8分提示中重度。
  • 阅片时需注意初始疾病严重程度较高的患者MRI磨玻璃影总分可能持续升高至24个月。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To determine factors influencing low-field MRI lung opacity severity 6-24 months after acute Covid-19 pneumonia.

MATERIALS AND METHODS: 104 post-acute Covid-19 patients with 167 MRI exams were included. 32 patients had more than one exam, and 63 exams were serial exams. Pulmonary findings were graded on a scale of 0-4 by quadrant, total score ranging from 0 (no opacity) to 16 (opacity > 75%), and score >8 considered moderate and >12 severe opacity. Kruskal-Wallis, Mann-Whitney, and Spearman rank correlation was used to assess the association of clinical and demographic factors with MR opacity severity at time intervals from acute infection. Random coefficients regression was used to assess whether opacity score changed over time.

RESULTS: Severity of initial illness was associated with increased MR opacity score at timeframes up to 24 months (p < .05). Among the 167 exams, moderate to severe MR opacities (total opacity score >8) were identified in 33% of exams beyond 6 months: 37% at 6 - <12 months (n = 23/63); 31% at 12- < 18 months (n = 13/42); 25% at 18- < 24 months (n = 6/24); and 50% at > 24 months (n = 3/6). No significant change in total opacity score over time was identified by random coefficients regression. Among the 32 patients with serial exams, 11 demonstrated no change in opacity score from initial to final exam, 10 decrease in score (mean 2.3, stdev 1.25, range 1-4), and 11 increase in score (average 2.8, stdev 1.48, range 1-7).

CONCLUSION: Initial Covid-19 disease severity was associated with increased MRI total opacity score at time intervals up to 24 months, and moderate to severe opacities were commonly identified by low-field MRI beyond 6 months from acute illness.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Azour L, Chandarana H, Maier C, et al. Low Field MRI Surveillance 6-24 Months Post-acute COVID-19 Pneumonia: Factors Influencing Severity and Evolution of Lung Opacities. Acad Radiol. 2024. PMID: 38443207. doi:10.1016/j.acra.2024.02.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。